Dengue Protease Substrate Recognition: Binding of the Prime Side-Reference-Cited by-同舟云学术

Dengue Protease Substrate Recognition: Binding of the Prime Side

Published:2016-09-22 Issue:10 Volume:2 Page:734-743
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Lin Kuan-Hung¹,Nalivaika Ellen A.¹,Prachanronarong Kristina L.¹,Yilmaz Nese Kurt¹,Schiffer Celia A.¹

Affiliation:

1. Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.6b00131

Reference38 articles.

1. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature

2. Immunopathological mechanisms in dengue and dengue hemorrhagic fever

3. The global distribution and burden of dengue

4. Dengue: the risk to developed and developing countries.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection;International Journal of Molecular Sciences;2024-04-16

2. Natural Polymorphisms D60E and I62V Stabilize a Closed Conformation in HIV-1 Protease in the Absence of an Inhibitor or Substrate;Viruses;2024-02-02

3. Aminopyrimidine Derivatives as Multiflavivirus Antiviral Compounds Identified from a Consensus Virtual Screening Approach;Journal of Chemical Information and Modeling;2024-01-09

4. Boophilin D1, a Kunitz type protease inhibitor, as a source of inhibitors for the ZIKA virus NS2B-NS3 protease;Biochimie;2023-11

5. Finding Lead Compounds for Dengue Antivirals from a Collection of Old Drugs through In Silico Target Prediction and Subsequent In Vitro Validation;ACS Omega;2023-08-28